GLIOBLASTOMA RESEARCH ORGANIZATION INC

EIN: 832388861 501(c)(3) Philanthropy & Grantmaking

MIAMI, FL

Total Revenue
$1,804,767
Total Expenses
$1,112,732
Total Assets
$1,432,059
Net Assets
$1,395,706
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2018
Legal Domicile
NY
Principal Officer
AMBER BARBACH
Phone
3059848164
Tax Period
2025-01-01 to 2025-12-31

GLIOBLASTOMA RESEARCH ORGANIZATION INC, founded in 2018, is a community nonprofit in the Philanthropy & Grantmaking sector that reported $1.8M in total revenue in fiscal year 2025. Revenue surged 76% from the prior year, signaling strong growth momentum. The organization ran a surplus of $692K, a strong 38% operating margin.

Mission

GLIOBLASTOMA RESEARCH ORGANIZATION, INC. IS A 501(C)(3) NONPROFIT ORGANIZATION THAT RAISES AWARENESS AND FUNDS FOR NEW GLOBAL, CUTTING-EDGE RESEARCH TO HELP FIND A CURE FOR GLIOBLASTOMA.

Program Service Accomplishments

Program 1
Expenses: $849,667

FOR DETAIL.THE ORGANIZATION TO DATE, HAS PROVIDED SUPPORT TO DOCTORS AND RESEARCHERS THROUGH SIXTEEN FULLY FUNDED PROJECTS AT LEADING CANCER CENTERS. THE ORGANIZATION ALSO DONATED OVER $675,000 IN...

Read more

FOR DETAIL.THE ORGANIZATION TO DATE, HAS PROVIDED SUPPORT TO DOCTORS AND RESEARCHERS THROUGH SIXTEEN FULLY FUNDED PROJECTS AT LEADING CANCER CENTERS. THE ORGANIZATION ALSO DONATED OVER $675,000 IN THE LAST FEW YEARS AND HAS PARTNERED WITH GBM-RELATED PROJECTS AROUND THE GLOBE. THE ORGANIZATION HAS THE OPPORTUNITY TO MEET WITH LEADERS IN NEURO-ONCOLOGY AS WELL AS CONNECT WITH THE PEOPLE AND FAMILIES DIRECTLY IMPACTED BY GLIOBLASTOMA. THE STORIES BEHIND THIS DEADLY CANCER DRIVE OUR RESEARCH FUNDING MISSION. FUELED BY OUR FOUNDER'S PERSONAL EXPERIENCE WITH GBM, THE GLIOBLASTOMA RESEARCH ORGANIZATION'S COMMUNICATIONS CHANNELS, SUCH AS SOCIAL MEDIA, SERVE AS A BRIDGE TO CONNECT THOSE ALL OVER THE WORLD WHO ARE SUFFERING FROM GLIOBLASTOMA OR HAVE BEEN AFFECTED BY THE DISEASE. THE ORGANIZATION PROVIDES A HUB FOR COMMUNICATION WHERE PEOPLE IN THE SAME SITUATION CAN SHARE THEIR EXPERIENCES.

Program 2
Expenses: $24,943

FOR DETAIL.THE ORGANIZATION HAS ESTABLISHED OVER 20 UNIQUE CAMPAIGNS, TO CONTINUE ITS ADVOCACY WORK, TO SHARE THE STORIES OF PATIENTS AND CAREGIVERS DEALING WITH BRAIN CANCER IN ONE WAY OR ANOTHER...

Read more

FOR DETAIL.THE ORGANIZATION HAS ESTABLISHED OVER 20 UNIQUE CAMPAIGNS, TO CONTINUE ITS ADVOCACY WORK, TO SHARE THE STORIES OF PATIENTS AND CAREGIVERS DEALING WITH BRAIN CANCER IN ONE WAY OR ANOTHER. THE GLIOBLASTOMA AKA GBM PODCAST, IN WHICH THE HOST HAS MEANINGFUL AND INSIGHTFUL CHATS WITHMEDICAL PROFESSIONALS, PATIENTS, CAREGIVERS, AND BIOTECH COMPANIES - TO FURTHER AWARENESS AND PROVIDE ANOTHER OUTLET FOR COMMUNITIES TO LEARN ABOUT BRAIN CANCER, IS NOW GOING INTO ITS THIRD SEASON WITH OVER 80,000 DOWNLOADS SINCE CREATION.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $1,775,406
Program Service Revenue $0
Investment Income $29,361
Other Revenue $0
TOTAL REVENUE $1,804,767

Expense Breakdown

Grants Paid $189,316
Salaries & Benefits $262,171
Fundraising Expenses $136,140
Program Expenses $874,610
Other Expenses $661,245
TOTAL EXPENSES $1,112,732

Year-over-Year Comparison

2025 2024 Change
Revenue $1,804,767 $1,025,244 +0.8%
Expenses $1,112,732 $807,776 +0.4%
Net Income $692,035 $217,468 +2.2%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
5
Independent Members
3
Employees
4
Volunteers
35

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
3
$127,693
Total Directors
5
$127,693
Key Employees
0
$0
Highest Compensated
1
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
AMBER BARBACH FOUNDER AND EXECUTIVE DIRECTOR 40.00
Officer Director
$108,429 $0 $108,429
ELISSA BARBACH VICE PRESIDENT 20.00
Officer Director
$19,264 $0 $19,264
KYLIE BARNES SECRETARY 1.00
Officer Director
$0 $0 $0
MARVIN LEW DIRECTOR 10.00
Director
$0 $0 $0
YONATAN BARDASH DIRECTOR 1.00
Director
$0 $0 $0
AZUL M DIEZ DEVELOPMENT DIRECTOR 40.00
Highest
$104,792 $0 $104,792
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2025 $1,804,767 $1,112,732 $1,432,059 $692,035
2024 $1,025,244 $807,776 $728,675 $217,468
2023 $832,005 $480,261 $492,941 $351,744
2022 $281,490 $260,309 $134,493 $21,181
Explore More Nonprofits
Top 100 Nonprofits in Florida Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare GLIOBLASTOMA RESEARCH ORGANIZATION INC with other nonprofits in Florida and across the country.